In our study, we showed the association of CSF levels of inflammatory (prostaglandins) and oxidative stress (Isoprostanes) related metabolites with biomarkers of AD pathology (Aβ-42, p-tau, t-tau). Here, MAPT is linked to Alzheimer disease.